Key result
ACS is linked to ~90% higher serum NT-proBNP levels compared to healthy controls.
Observational (n=90)
No
Absolute Event Rate: 204.95% vs 107.79%
p-value: p=0.0144
Serum NT-proBNP and hs-CRP are significantly elevated in patients with acute coronary syndrome compared to healthy controls and vary by ACS subtype.
NT-proBNP elevation was associated with ACS; leaves open its diagnostic or prognostic utility pending prospective validation.
Plaque disruption exposes thrombogenic substances that may produce an extensive thrombus in the infarct-related artery. The precursor of BNP and N-terminal pro -Brain Natriuretic Peptide (NT-proBNP) is a pre-pro hormone BNP, The prohormone is released during homodynamic stress from the left and right cardiac ventricle in response to ventricular volume expansion and pressure overload. Recent data suggest that left ventricular end diastolic wall stress and wall stiffness may be the predominate triggers of BNP release. Objective: To determine the level of serum NT-PRO brain natriuretic peptide which marked an increased incidence of cardiovascular events in unselected community-based individuals with many types of acute coronary syndrome admitted to cardiology care unite within 24 hour. Patients and Methods: This prospective study was composed of 70 consecutive patients with ACS who were seen between April 2015 to April 2017, and 20 healthy subjects as control group. The present study was conducted at the Department of Bio Chemistry, College of Medicine, University of Baghdad and Baghdad Teaching Hospital. Routine blood samples were collected at admission with fasting status, and the troponin I, C-reactive protien , and BNP levels were measured, a specific kit for the ELIZA Centaur analyzer was used. Glucose level was measured by using enzymatic colorimetric method. the patients were divided into five groups according to type of ACS: Extensive MI, Anteroseptal MI, Anterior MI, Inferior MI, and Unstable angina. Electrocardiography and Echocardiography were performed upon hospital admission for each patient. Results: This study included 70 patients with meanSD of age was (58.7711.45) years ranged from (25-84) years divided into two groups: Male group included 52(74.3%) patients, and female group included 18 (25.7%) patients. The patients with ACS were found to have significantly higher mean ( SEM) value of serum NT-PROBNP concentrations (p=0.0144) as compared with mean ( SEM) value of serum control group, There was significant difference in mean ( SEM) value of NT-PROBNP concentrations among the five patients groups,(P-value=0.0255). The patients with ACS were found to have significantly higher mean (SEM) value of serum hs-CRP concentrations (p=0.002) as compared with mean (SEM) value of serum control group. There was significant difference in mean( SEM) value of hs-CRP concentrations among the five patients groups, (P-value=0.0478). The mean (SEM) value of serum hs-troponin I concentrations did not differ significantly (p=0.372) as compared with mean (SEM) value of serum control group. There was non significant difference in mean( SEM) value of serum hs-troponin I concentrations among the five patients groups, (P-value=0.146). Conclusions: Analysis of NT-proBNP help emergency physicians in managing patients with a variety of conditions. They are primarily helpful in difficult-to-diagnose causes of dyspnea. They are a strong tool in the ED to differentiate ACS from its various mimics and are also helpful in monitoring of ACS therapy.
No takes yet. Share an insight, caveat, or question.
Wafa M. Merza (2017) conducted an observational in Acute Coronary Syndrome (n=90). Serum NT-PROBNP measurement vs. Healthy controls was evaluated on Serum NT-PROBNP concentration (ng/L) (p=0.0144). Serum NT-PROBNP concentrations were significantly higher in patients with acute coronary syndrome compared to healthy controls (204.95 vs 107.79 ng/L, p=0.0144).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: